Alucent Biomedical logo

Alucent Biomedical

Salt Lake City, UT

Alucent Biomedical is a biomedical company that develops a combination drug-device therapy called Natural Vascular Scaffolding (NVS) for the treatment of vascular diseases. NVS is a first-of-a-kind combination drug-device therapy designed to assist the body in naturally opening and maintaining arterial patency. The therapy focuses on peripheral artery disease (PAD), arteriovenous fistula (AVF) maturation for dialysis, and more.

alucentmedical.com

Company Details

Founded

2017

Employees

Between 20 - 50 employees

Raised

$46,600,000

Headquarters Location

Salt Lake City, UT

Public

No

Acquired

No

CEO

Myles GreenbergMyles Greenberg

Founders

Ron Utecht
Ron Utecht

Company Collections

These are collections Alucent Biomedical is a part of. Click on the collection name to view similar companies.

Alucent Biomedical's Tech Stack